Cobra venom factor: evidence for its being altered cobra C3 (the third component of complement)
- PMID: 56780
- DOI: 10.1126/science.56780
Cobra venom factor: evidence for its being altered cobra C3 (the third component of complement)
Abstract
Evidence is presented that cobra venom factor, the anticomplementary protein in Naja naja venom, is modified cobra C3 (the third component of complement). Antiserum to the cobra venom factor cross reacts with human C3. A protein in cobra serum reacts strongly with antiserum to the venom factor and the former protein, like human C3, is converted by incubation of cobra serum with endotoxin, hydrazine, or simple storage at 37 degrees C. Incubation of cobra venom factor with cobra serum destroys the C3 cleaving activity of the venom factor in human serum, whereas human C3b inactivator is ineffective. Thus, the cobra venom factor appears to be a form of C3 (perhaps C3b); its potent action in human serum probably derives from its lack of sensitivity to human C3b inactivator.
Similar articles
-
Complement in the serum and venom of Brazilian snakes (Crotalidae).Acta Pathol Microbiol Immunol Scand Suppl. 1984;284:97-103. Acta Pathol Microbiol Immunol Scand Suppl. 1984. PMID: 6587747
-
Antigenic relationships between human and cobra complement factors C3 and cobra venom factor (CVF) from the Indian cobra (Naja naja).J Immunol. 1983 Oct;131(4):1920-3. J Immunol. 1983. PMID: 6194220
-
Preparation of complement fragments C3b and C3a from purified rat complement component C3 by activated cobra venom factor.J Pharmacol Toxicol Methods. 2005 Sep-Oct;52(2):260-3. doi: 10.1016/j.vascn.2004.12.001. J Pharmacol Toxicol Methods. 2005. PMID: 16125624
-
Recombinant cobra venom factor.Mol Immunol. 2004 Jun;41(2-3):191-9. doi: 10.1016/j.molimm.2004.03.011. Mol Immunol. 2004. PMID: 15159065 Review.
-
The cobra complement system: I. The alternative pathway of activation.Dev Comp Immunol. 1985 Spring;9(2):311-25. doi: 10.1016/0145-305x(85)90122-3. Dev Comp Immunol. 1985. PMID: 3894085 Review.
Cited by
-
The membrane attack complex.Springer Semin Immunopathol. 1984;7(2-3):93-141. doi: 10.1007/BF01893017. Springer Semin Immunopathol. 1984. PMID: 6387983 Review. No abstract available.
-
Suppression of inflammation in a mouse model of rheumatoid arthritis using targeted lipase-labile fumagillin prodrug nanoparticles.Biomaterials. 2012 Nov;33(33):8632-40. doi: 10.1016/j.biomaterials.2012.08.005. Epub 2012 Aug 24. Biomaterials. 2012. PMID: 22922023 Free PMC article.
-
Requirements for beta1H globulin and C3b inactivator in the control of the alternative complement pathway in human serum.Immunology. 1978 Dec;35(6):1045-9. Immunology. 1978. PMID: 83964 Free PMC article.
-
Partial amino acid sequence of human factor D:homology with serine proteases.Proc Natl Acad Sci U S A. 1980 Feb;77(2):1116-9. doi: 10.1073/pnas.77.2.1116. Proc Natl Acad Sci U S A. 1980. PMID: 6987665 Free PMC article.
-
Reduction in alternative complement pathway mediated C3 conversion following burn injury.Ann Surg. 1981 Aug;194(2):224-31. doi: 10.1097/00000658-198108000-00018. Ann Surg. 1981. PMID: 7259350 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous